ARTICLE | Company News
FDA approves Celltech's Metadate CD
April 4, 2001 7:00 AM UTC
The FDA granted marketing approval to Celltech Group (LSE:CCH; CLL) for its Metadate methylphenidate CD extended-release capsules to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients s...